Researcher
Jan Brughmans
- Keywords:Applied biological sciences, biotechnology
- Disciplines:Other biological sciences not elsewhere classified
Affiliations
- Brussels Center for Immunology (Research group)
Member
From1 Jan 2023 → Today - FORMER_Cellular and Molecular Immunology (Research group)
Member
From1 Jan 2021 → 30 Jun 2021 - Department of Bio-engineering Sciences (Department)
Member
From1 Sep 2019 → Today
Publications
1 - 4 of 4
- Flt3L therapy increases the abundance of Treg-promoting CCR7+ cDCs in preclinical cancer models(2023)
Authors: Emile J. Clappaert, Daliya Kancheva, Jan Brughmans, Ayla Debraekeleer, Pauline M.R. Bardet, Yvon Elkrim, Dagmar Lacroix, Maida Živalj, Ahmed E.I. Hamouda, Jo A. Van Ginderachter, et al.
- Junctional adhesion molecule-A is dispensable for myeloid cell recruitment and diversification in the tumor microenvironment(2022)
Authors: Mate Kiss, Els Lebegge, Aleksandar Murgaski, Helena Van Damme, Daliya Kancheva, Jan Brughmans, Isabelle Scheyltjens, Ali Talebi, Robin Maximilian Awad, Yvon Elkrim, et al.
- Efficacy of CD40 agonists is mediated by distinct cDC subsets and subverted by suppressive macrophages(2022)
Authors: Aleksandar Murgaski, Mate Kiss, Helena Van Damme, Daliya Kancheva, Isaure Vanmeerbeek, Jiri Keirsse, Eva Hadadi, Jan Brughmans, Sana M. Arnouk, Ahmed E.I. Hamouda, et al.
Pages: 3785-3801 - IL1β Promotes Immune Suppression in the Tumor Microenvironment Independent of the Inflammasome and Gasdermin D(2021)
Authors: Mate Kiss, Lieselotte Vande Walle, Pedro H V Saavedra, Els Lebegge, Helena Van Damme, Aleksandar Murgaski, Junbin Qian, Manuel Ehling, Samantha Pretto, Evangelia Bolli, et al.
Pages: 309-323